Health Highlights, April 7, 2022
By Robin Foster HealthDay Reporter
Is the CDC in crisis? Former agency heads debate its future. A handful of former directors say they support a sweeping review of the agency that's been ordered up by current director Dr. Rochelle Walensky. Read more
Experimental pill may fight antibiotic-resistant UTIs. The new pill, called tebipenem HBr, worked as well as a standard IV antibiotic in treating patients hospitalized with "complicated" UTIs, a study has found. Read more
Upped risk for clots lasts at least 6 months after COVID. A new study suggests that COVID-19 is an independent risk factor for deep vein thrombosis, pulmonary embolism and bleeding, researchers say. Read more
U.S. nursing home industry needs an overhaul. A major new report finds facilities awash in ineffective care and staffing shortages. Its authors call for sweeping changes in an industry whose failures have only been exacerbated by the pandemic. Read more
Are retooled COVID booster shots coming this fall? Federal health officials told an expert advisory panel on Wednesday that clinical trials of potential candidates would have to begin by next month, and a final formula chosen by June. Read more
The news stories provided in Health News and our Health-E News Newsletter are a service of the nationally syndicated HealthDay® news and information company. Stories refer to national trends and breaking health news, and are not necessarily indicative of or always supported by our facility and providers. This information is provided for informational and educational purposes only, and is not intended to be a substitute for medical advice, diagnosis, or treatment.